https://finfeed.com/small-caps/biotech/holistas-viral-protection-products-in-demand/HCT is going from R&D to global roll out right now, distribution deals and expansion is key! It is only going to take one or two significant off-takes of current products and then ramp up and marketing of other products for chart to break out.... Especially on minimum order/sales/distributor success updates like winning major tender bids with $$$ and terms attached. That is the punt. Buy in around this range if you believe the company is going to succeed if you don't the GTFO and go focus on being productive.
It is hard to predict a market cap but marketing and deal making seem to be happening with Health Global Therapies, Ooh-Medical , Kawan Foods etc.... and this is where HCT shareholders need the business to focus. Well this and then securing the ability to supply at scale.
From my knowledge they have factory and ability to supply 80less and low GI foods from Malaysia and other regions easily enough but of course the focus is on Natshield range right now..
So far from what I have read, factory ability for Natshield product in;
Malaysia 2 sites?
Phillipines 2 sites?
US 3 sites
UK(Through Ooh-Medical) - Next news is on minimum sales orders and hopefully NHS / hopsital role out!
Australia 2 sites WA/Vic
The other threads are being taken over by trolls. I genuinely don't get it... but I guess it is just a bunch of folk down on their luck and attacking fellow retail investors like themselves when SP moves south as they hide behind anonymous screens... Feel empathy for them ,...It's either complete down ramping trolls or dudes that have serious self esteem issues who come back once sold and berate everyone like they had any idea...
I feel anywhere around this level is good buying opportunity so will back it up next week as expect news to start flowing again after Ramadan and Malaysia holidays... Good thing is the rest of business should be pumping along!
